Daily Schedule

Friday, July 18

7:00 am	Registration Opens/Continental Breakfast
7:30-7:40 am	Review of Purpose and Learning Objectives	Dr. Basile
7:40-8:10 am	Changing Paradigms for Type 1 and Type 2 Diabetes-Not As We Learned in Medical School	Dr. Soule
8:10-8:40 am	When and How to Initiate Insulin Therapies in Type 2 Diabetes	Dr. Mayfield
8:40-9:10 am	The 10 Minute Diabetes Office Visit	Ms. Arnold
9:10-9:30 am	Refreshment Break
9:30-10:00 am	Intensifying Insulin Therapies to Get to Goal	Dr. Mayfield
10:00-10:30 am	Incretin-Based Therapy for Diabetes: When and How?	Dr. Soule
10:30-11:00 am	Helping Your Diabetic Patient Make Changes in Self-Care Decisions	Ms. Arnold
11:00-11:30 am	Ask the Experts Panel Discussion	Dr. Basile, Moderator, Dr. Soule, Ms. Arnold, Dr. Mayfield
11:30 am- 12:30 pm	Interesting Cases in Diabetes	Drs. Soule and Mayfield; Dr. Gerstein panelist
12:30 pm	Adjourn

7:00 am	Continental Breakfast
7:30-7:40 am	Review of Yesterday’s Key Points	Dr. Basile
7:40-8:10 am	The Clinical Risks of Obesity and Body Fat	Dr. Lackland
8:10-8:40 am	Should BP be Treated in Prehypertensive Patients with the Cardiometabolic Syndrome – If so, to What Goal?	Dr. Egan
8:40-9:10 am	Should Glucose be Treated in Those with the Cardiometabolic Syndrome-If so, to What Goal?	Dr. Gerstein
9:10-9:30 am	Refreshment Break
9:30-10:00 am	How to Evaluate the Cardiovascular Literature-A Focus on Recent Clinical Trials	Dr. Lackland
10:00-10:30 am	Contemporary Approaches to the Management of Resistant Hypertension	Dr. Egan
10:30-11:00 am	What Should Our Goal be for Glycosylated Hemoglobin in Type 1 and Type 2 Diabetics-A Focus on Recent Trials	Dr. Lackland
11:00-11:30 am	Ask the Experts Panel Discussion of Morning Lectures	Dr. Basile, Moderator, Dr. Lackland, Dr. Egan, and Dr. Gerstein
11:30 am- 12:30 pm	Interesting Cases in Hypertension	Dr. Clyburn presenting. Panel: Drs. Lackland, and Egan
12:30 pm	Adjourn

7:00 am	Continental Breakfast
7:30-7:40 am	Review of Yesterday’s Key Points	Dr. Basile
7:40-8:10 am	Do We Continue to See an Incremental Benefit from LDL-Cholesterol Reduction Beyond Our Current Goals?	Dr. Guyton
8:10-8:40 am	Once Our Goal LDL-Cholesterol is Reached, What Should We Do About Residual Risk That Exists for Further ASCVD?	Dr. Prisant
8:40-9:10 am	An Approach to Treating Lipids in Those with Diabetes-Does it Matter What Your Baseline LDL-Cholesterol Is?	Dr. Guyton
9:10-9:30 am	Refreshment Break
9:30-10:00 am	The Approach to Treating Lipids in Those with Chronic Kidney Disease-Is There Evidence for a Specific LDL-Cholesterol Goal?	Dr. Prisant
10:00-11:00 am	Interesting Cases in Lipids	Drs. Guyton, Prisant, and Basile
11:00-11:30 am	The Lipid Association Qualifying Exam	Drs. Guyton and Prisant
11:30 am- 12:00 noon	Update on the ASH-Carolinas Georgia Florida Chapter	Dr. Raij
12:00 noon	Adjourn